Third Circuit backs pharma firm in antitrust clash

13-12-2022

Staff Writer

Third Circuit backs pharma firm in antitrust clash

Jonathan Weiss / Shutterstock.com

Years-long dispute centred on treatment for gastroesophageal reflux disease | Case invited questions concerning Noerr-Pennington doctrine and immunity | Takeda | Zydus.


Takeda, Zydus Pharmaceuticals, ANDA, generics, Prevacid, antitrust litigation, patent infringement

LSIPR